Topical Ocular Sodium 4-Phenylbutyrate Rescues Glaucoma in a Myocilin Mouse Model of Primary Open-Angle Glaucoma

被引:94
|
作者
Zode, Gulab S. [1 ,2 ]
Bugge, Kevin E. [1 ,2 ]
Mohan, Kabhilan [3 ]
Grozdanic, Sinisa D. [3 ]
Peters, Joseph C. [2 ]
Koehn, Demelza R. [4 ]
Anderson, Michael G. [4 ,5 ]
Kardon, Randy H. [3 ,5 ]
Stone, Edwin M. [1 ,5 ]
Sheffield, Val C. [1 ,2 ,5 ]
机构
[1] Univ Iowa, Howard Hughes Med Inst, Iowa City, IA 52242 USA
[2] Univ Iowa, Dept Pediat, Iowa City, IA 52242 USA
[3] Iowa State Univ, Coll Vet Med, Dept Vet Clin Sci, Ames, IA USA
[4] Univ Iowa, Dept Mol Physiol & Biophys, Iowa City, IA 52242 USA
[5] Univ Iowa, Dept Ophthalmol & Visual Sci, Iowa City, IA 52242 USA
基金
美国国家卫生研究院;
关键词
EXTRACELLULAR-MATRIX PROTEINS; ENDOPLASMIC-RETICULUM STRESS; NERVE HEAD CELLS; CHEMICAL CHAPERONES; ER STRESS; OPTIC-NERVE; NON-SECRETION; GENE; PHENYLBUTYRATE; LOCALIZATION;
D O I
10.1167/iovs.11-8837
中图分类号
R77 [眼科学];
学科分类号
100212 ;
摘要
PURPOSE. Mutations in the myocilin gene (MYOC) are the most common known genetic cause of primary open-angle glaucoma (POAG). The purpose of this study was to determine whether topical ocular sodium 4-phenylbutyrate (PBA) treatment rescues glaucoma phenotypes in a mouse model of myocilin-associated glaucoma (Tg-MYOCY437H mice). METHODS. Tg-MYOCY437H mice were treated with PBA eye drops (n = 10) or sterile PBS (n = 8) twice daily for 5 months. Long-term safety and effectiveness of topical PBA (0.2%) on glaucoma phenotypes were examined by measuring intraocular pressure (IOP) and pattern ERG (PERG), performing slit lamp evaluation of the anterior chamber, analyzing histologic sections of the anterior segment, and comparing myocilin levels in the aqueous humor and trabecular meshwork of Tg-MYOCY437H mice. RESULTS. Tg-MYOCY437H mice developed elevated IOP at 3 months of age when compared with wild-type (WT) littermates (n = 24; P < 0.0001). Topical PBA did not alter IOP in WT mice. However, it significantly reduced elevated IOP in Tg-MYOCY437H mice to the level of WT mice. Topical PBA-treated Tg-MYOCY437H mice also preserved PERG amplitudes compared with vehicle-treated Tg-MYOCY437H mice. No structural abnormalities were observed in the anterior chamber of PBA-treated WT and Tg-(MYOCH)-H-Y437 mice. Analysis of the myocilin in the aqueous humor and TM revealed that PBA significantly improved the secretion of myocilin and reduced myocilin accumulation as well as endoplasmic reticulum (ER) stress in the TM of Tg-MYOCY437H mice. Furthermore, topical PBA reduced IOP elevated by induction of ER stress via tunicamycin injections in WT mice. CONCLUSIONS. Topical ocular PBA reduces glaucomatous phenotypes in Tg-MYOCY437H mice, most likely by reducing myocilin accumulation and ER stress in the TM. Topical ocular PBA could become a novel treatment for POAG patients with myocilin mutations. (Invest Ophthalmol Vis Sci. 2012;53:1557-1565) DOI:10.1167/iovs.11-8837
引用
收藏
页码:1557 / 1565
页数:9
相关论文
共 50 条
  • [31] Is primary open-angle glaucoma an ocular manifestation of systemic disease?
    Stephanie Wey
    Sarah Amanullah
    George L. Spaeth
    Melih Ustaoglu
    Kamran Rahmatnejad
    L. Jay Katz
    Graefe's Archive for Clinical and Experimental Ophthalmology, 2019, 257 : 665 - 673
  • [32] MICROCIRCULATION AND HEMODYNAMICS IN OCULAR HYPERTENSION AND PRIMARY OPEN-ANGLE GLAUCOMA
    ALEXEEV, BN
    SHMYREVA, VF
    MOSTOVOI, EN
    VESTNIK OFTALMOLOGII, 1986, (05) : 8 - 10
  • [33] Is primary open-angle glaucoma an ocular manifestation of systemic disease?
    Wey, Stephanie
    Amanullah, Sarah
    Spaeth, George L.
    Ustaoglu, Melih
    Rahmatnejad, Kamran
    Katz, L. Jay
    GRAEFES ARCHIVE FOR CLINICAL AND EXPERIMENTAL OPHTHALMOLOGY, 2019, 257 (04) : 665 - 673
  • [34] FLUORESCEIN ANGIOGRAPHY IN LOW TENSION GLAUCOMA, PRIMARY OPEN-ANGLE GLAUCOMA AND OCULAR HYPERTENSION
    GEIJSEN, HC
    GREVE, EL
    OPHTHALMOLOGICA, 1986, 192 (02) : 109 - 109
  • [35] Corneal thickness in ocular hypertension, primary open-angle glaucoma, and normal tension glaucoma
    Copt, RP
    Thomas, R
    Mermoud, A
    ARCHIVES OF OPHTHALMOLOGY, 1999, 117 (01) : 14 - 16
  • [36] Mortality in primary open-angle glaucoma and exfoliative glaucoma
    Tarkkanen, Ahti H. A.
    Kivela, Tero T.
    EUROPEAN JOURNAL OF OPHTHALMOLOGY, 2014, 24 (05) : 718 - 721
  • [37] Comparative Efficacy and Tolerability of Topical Prostaglandin Analogues for Primary Open-Angle Glaucoma and Ocular Hypertension
    Lin, Liang
    Zhao, Ying Jiao
    Chew, Paul T. K.
    Sng, Chelvin C. A.
    Wong, Hon-Tym
    Yip, Leonard W.
    Wu, Tuck Seng
    Bautista, Dianne
    Teng, Monica
    Khoo, Ai Leng
    Lim, Boon Peng
    ANNALS OF PHARMACOTHERAPY, 2014, 48 (12) : 1585 - 1593
  • [38] Effectiveness and Safety of Topical Bimatoprost Insert for Primary Open-Angle Glaucoma and Ocular Hypertension Treatment
    Cronemberger, Sebastiao
    Franca, Jucara R.
    Faria Araujo, Alan Cezar
    da Cunha, Francine Rubiao
    Gomes Faraco, Andre Augusto
    Ferreira, Anderson
    Foureaux, Giselle
    INVESTIGATIVE OPHTHALMOLOGY & VISUAL SCIENCE, 2017, 58 (08)
  • [39] OCULAR HYPERTENSION OR EARLY GLAUCOMA - OCULAR HYPERTENSION VS OPEN-ANGLE GLAUCOMA
    CHANDLER, PA
    GRANT, WM
    ARCHIVES OF OPHTHALMOLOGY, 1977, 95 (04) : 585 - 586
  • [40] Myocilin levels in the aqueous humor of open-angle glaucoma patients
    Ghanem, Asaad A.
    El-Awady, Hatem E.
    Wolfs, Roger C. W.
    Arafa, Lmiaa F.
    INTERVENTIONAL MEDICINE AND APPLIED SCIENCE, 2012, 4 (01): : 42 - 47